40 results
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
additional expenses attributable to adjusting our development plans (including any supply-related matters) to the COVID-19 pandemic;
the scope … ;
general market conditions or extraordinary external events, such as a recession or the COVID-19 pandemic;
the changing and volatile U.S. and global
424B5
1r6k 4rttx
1 Dec 23
Prospectus supplement for primary offering
5:23pm
424B5
5t9ju9tmur pdfkj
26 Oct 23
Prospectus supplement for primary offering
4:29pm
424B4
ojcnva90 2i
27 Sep 23
Prospectus supplement with pricing info
5:26pm
424B4
yo68 fyr7ksrfssg
7 Jun 23
Prospectus supplement with pricing info
5:29pm
424B5
reqk2nn3ipg8 ipi7crd
14 Apr 23
Prospectus supplement for primary offering
7:10am